GLS and cholangiocarcinoma: In addition to the effective reduction of cancer progression markers in resistant cells by glutamine deprivation alone, studies have found that the combination of Glutaminase 1(GLS1) inhibition and glucose transporter (GLUT) inhibition, that is, simultaneous inhibition of glutamine and glucose uptake, more effectively reverses cisplatin resistance in cholangiocarcinoma cells [34].